Quick Answer: Prescribing Schedule 8 (S8) and other controlled medications carries significant legal and professional obligations. From state-based permit requirements to documentation standards and real-time monitoring, getting it wrong can lead to AHPRA complaints, Medicare scrutiny, or criminal charges. This guide explains what every GP needs to know. 

No area of general practice generates more medico-legal anxiety than the prescribing of controlled medications. Opioids, benzodiazepines, stimulants for ADHD, and medical cannabis all attract heightened regulatory attention — and for good reason. These medications carry serious risks of dependence, misuse, and diversion. 

For GPs, the challenge is navigating a complex, state-based regulatory framework while also managing the therapeutic needs of patients who may genuinely benefit from these medications. This guide focuses on the legal and professional obligations — not the clinical guidelines — that every Australian GP needs to understand. 

The Schedule 8 Framework: An Overview 

In Australia, medications are classified into Schedules under the Poisons Standard (the SUSMP), a nationally coordinated document maintained by the Therapeutic Goods Administration (TGA). Schedule 8 (S8) medications are controlled drugs — substances with a high potential for dependence or misuse that are subject to strict regulatory controls. 

Common S8 medications encountered in general practice include: 

  • Opioids: morphine, oxycodone, fentanyl, hydromorphone, buprenorphine (for pain management) 
  • Stimulants: dexamphetamine and methylphenidate (used for ADHD) 
  • Benzodiazepines: classified as S8 in most states when prescribed beyond certain durations or doses 
  • Methadone and buprenorphine/naloxone: for opioid dependence treatment 
  • Gamma-hydroxybutyrate (GHB) and its precursors 

While the Poisons Standard is national, the prescribing, storage, record-keeping, and permit requirements for S8 medications are primarily state and territory-based. This means your obligations differ depending on where you practise. 

State-Based Permit Requirements 

In most Australian states and territories, prescribing S8 medications for longer than a set period — typically 2 to 8 weeks depending on the medication and jurisdiction — requires a permit from the relevant state health authority. This is one of the most commonly misunderstood obligations. 

  • NSW: Authority required for ongoing Schedule 8 prescribing (NSW Health Pharmaceutical Regulatory Unit) 
  • VIC: Permit required to prescribe S8 substances beyond initial treatment periods (Department of Health) 
  • QLD: Approval to prescribe certain S8 medications (Queensland Health) 
  • WA: S8 prescribing approval through WA Health 
  • SA: Approval required for ongoing S8 prescribing 

Prescribing S8 medications without the required permit or authority is both a regulatory breach and a potential criminal offence. If you are transitioning a patient from emergency or acute management onto long-term S8 prescribing, check whether a permit is required in your jurisdiction before the initial authority expires. 

Don’t Assume the Hospital Obtained Authority: A common pitfall – a patient is discharged from hospital on an S8 medication that was properly authorised within the hospital setting. Once you take over community prescribing, that authority does not automatically transfer to you as the treating GP. You need to apply for your own authority before continuing to prescribe. 

Real-Time Prescription Monitoring: SafeScript and DAMMPS 

Real-time prescription monitoring (RTPM) systems allow prescribers and pharmacists to view a patient’s recent prescription history for monitored medications. These systems are now operational across all Australian states and territories. 

  • Victoria: SafeScript — mandatory checking is required before prescribing S8 and certain S4 medications 
  • NSW: DAMMPS (Drug and Alcohol Medication Management Pharmaceutical Specialist) — check via the NSW Health portal 
  • Queensland, SA, WA, TAS, ACT, NT: similar real-time monitoring systems are in place 

In jurisdictions where checking is mandatory, failing to do so before prescribing a monitored medication is a regulatory breach. Even where checking is not mandatory, failure to check RTPM in circumstances where a patient presents risk factors for misuse or diversion can support a finding of below-standard prescribing. 

Key point: RTPM gives you a real-time view of whether a patient is obtaining the same or similar medications from multiple prescribers — a clear red flag for prescription misuse or diversion. 

Documentation Standards for S8 Prescribing 

Your clinical records for S8 prescribing need to reflect a higher standard of documentation than a routine prescription. At minimum, your notes should clearly record: 

  • The clinical indication for the medication 
  • The dose, frequency, and quantity prescribed 
  • The outcome of any RTPM check (including date and any findings) 
  • Discussion of risks and benefits with the patient 
  • Any monitoring plan (including urine drug screening, dose review dates) 
  • Evidence of any permit or authority number 
  • Basis for any dose escalation 

Prescribing an S8 medication without contemporaneous documentation of the clinical reasoning is a significant risk. In a complaint or investigation, your records are your primary defence. 

Clinical Scenario: The Inherited Opioid Patient: Dr Walters joins a new practice. One of her inherited patients, Mr Romano, is on long-term oxycodone for chronic back pain. The previous GP had applied for and received an S8 authority two years ago. The records show escalating doses over the past 12 months, and there is no documentation of a recent urine drug screen or dose review. 

What Dr Walters should do: Before writing any further prescriptions, verify that the S8 authority is still current and applies to her as the new treating practitioner. Conduct an RTPM check. Schedule a formal medication review. Request updated urine drug screening. Document the clinical basis for continuing (or modifying) the prescribing plan. Consider whether a pain specialist or addiction medicine referral is appropriate. Do not simply continue the existing script without proper clinical review — the obligation to prescribe appropriately runs from the moment she takes over care. 

ADHD Medications: A Special Category 

Stimulant medications for ADHD — primarily dexamphetamine and methylphenidate — are Schedule 8 medications subject to their own specific regulatory frameworks. In most jurisdictions, the right to initiate stimulant prescribing for ADHD is restricted to specialists (typically paediatricians, psychiatrists, or neurologists). GPs can generally continue prescribing once a specialist has initiated treatment, but rules vary significantly by state. 

  • NSW: Stimulant prescribing for ADHD requires a Stimulant Authority through NSW Health. GPs can apply for authority to prescribe in continuation of specialist-initiated treatment. 
  • VIC: Similar framework — specialist initiation required, GPs can apply for continued prescribing authority. 
  • QLD, WA, SA: State-specific frameworks — check with the relevant health department. 

With ADHD diagnoses increasing significantly in adolescents and adults, GPs are under increasing pressure from patients to initiate or accelerate access to stimulant medications. Prescribing stimulants without the required authority — regardless of the clinical merits — is a serious regulatory breach. 

Medical Cannabis Prescribing 

Medical cannabis (medicinal cannabis) was legalised in Australia in 2016 for clinical use with TGA approval. The prescribing framework has evolved significantly since then. Key points for GPs: 

  • GPs can prescribe medical cannabis through the TGA’s Special Access Scheme (SAS-B) or the Authorised Prescriber pathway 
  • THC-containing products are Schedule 8; CBD-only products are Schedule 4 
  • Some states require additional state-based approval for medical cannabis prescribing 
  • Documentation requirements mirror those for other S8 medications, with additional requirements around TGA approval numbers and product details 
  • Medical cannabis cannot be prescribed via telehealth in all jurisdictions — check current rules before prescribing remotely 

For updated information on the medical cannabis prescribing framework, refer to the TGA’s website at www.tga.gov.au/medicinal-cannabis. 

When You Suspect Prescription Misuse or Diversion 

Managing patients who appear to be misusing or diverting controlled medications is one of the most clinically and legally difficult aspects of S8 prescribing. Your obligations in this situation include: 

  • Check RTPM to establish whether the patient is obtaining medications from multiple sources 
  • Consider requesting urine drug screening — noting that patients can decline, and that a refusal is a clinical data point in itself 
  • Consider a formal medication review or referral to a specialist in addiction medicine 
  • Document your clinical reasoning clearly 
  • Consider whether you are required to make any notifications (for example, in relation to a patient who holds a firearms licence) 

If you have concerns about prescription fraud — for example, a patient presenting with an altered or forged prescription — you should report this to police. Prescriptions for S8 medications are legal documents and their alteration is a criminal offence. Document the incident and retain the prescription if clinically appropriate to do so. 

Prescribing S8 Medications via Telehealth 

The rules around prescribing S8 medications via telehealth have been a significant source of compliance risk since the expansion of telehealth following COVID-19. Key points: 

  • A continuing patient-doctor relationship must generally be established before S8 medications can be prescribed via telehealth — initiating a new course of S8 prescribing for a new patient via telehealth only is high-risk 
  • Some states require the prescriber to have physically examined the patient before prescribing certain S8 medications, regardless of telehealth use 
  • RTPM checks must still be performed before telehealth S8 prescribing 
  • State-based permit requirements apply regardless of the consultation modality 

The TGA and state health authorities have issued specific guidance on telehealth prescribing of controlled medications — review this guidance carefully before prescribing S8 medications via telehealth. 

Frequently Asked Questions 

Q: A patient says they lost their S8 script. Can I give them another one? 

With caution. There is no absolute prohibition on issuing a replacement prescription, but this is a scenario frequently associated with drug-seeking behaviour. Check RTPM before making any decision. Document the clinical reasoning. Consider whether a shorter supply or pharmacy-supervised dispensing is appropriate. A pattern of ‘lost’ scripts is a red flag. 

Q: Can I prescribe S8 medications to a patient who is also seeing a pain specialist? 

Potentially — but you need to be aware of what the specialist has prescribed, and ideally coordinate with them. Prescribing the same S8 medication from two separate sources significantly increases the risk of overdose and diversion. Check RTPM and communicate with the specialist before prescribing. 

Q: A patient is threatening to make a complaint if I don’t prescribe their opioids. What do I do? 

Your prescribing decision must be based on clinical grounds — not on threats. A complaint threat does not create a clinical indication. Document the interaction. Consider whether the pattern of behaviour warrants formal termination of the therapeutic relationship. Contact your medico-legal insurer if a complaint follows. See our related article: Managing Threatening or Aggressive Patients. 

Q: Do I need a permit to prescribe buprenorphine for opioid dependence treatment? 

Yes, in most jurisdictions. Opioid dependence treatment (ODT) with methadone and buprenorphine/naloxone is subject to specific credentialing and approval requirements. GPs wanting to provide ODT typically need to complete specific training and obtain approval from their state health authority. Contact your state health department for current requirements. 

Q: I’ve been prescribing S8 medications for years without a permit. What should I do? 

Seek advice from your medico-legal insurer immediately. Do not simply stop prescribing without a transition plan — this could cause patient harm. The approach to regularising your prescribing practices will depend on your jurisdiction and circumstances. Acting promptly and transparently is generally viewed more favourably than continuing to prescribe outside the regulatory framework.